A Randomized, Double-Blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD).
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2018
At a glance
- Drugs Glycopyrrolate/indacaterol (Primary) ; Indacaterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Sep 2009 Results were presented at the 19th Annual Congress of the European Respiratory Society (ERS-2009).
- 09 Sep 2008 Status changed from recruiting to completed, according to ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History